Status:
COMPLETED
Reducing Suicidal Ideation Through Treatment of Nightmares-Post Traumatic Stress Disorder (PTSD)
Lead Sponsor:
Augusta University
Conditions:
Post Traumatic Stress Disorder
Suicidal Ideation
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Patients with PTSD, and frequent nightmares, and mild-moderate suicidal ideation, who are already taking a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor ...
Eligibility Criteria
Inclusion
- PTSD
- Frequent nightmares
- Suicidality
Exclusion
- Schizophrenia
- Bipolar
- Substance abuse
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02199652
Start Date
March 1 2014
End Date
December 1 2017
Last Update
September 18 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgia Regents University
Augusta, Georgia, United States, 30912